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Abstract
Background: Breast cancer is the second cause of death in women 
worldwide. The spontaneous breast nipple discharge may contain 
cells that can be analyzed for malignancy. Halo® Mamo Cyto Test 
(HMCT) was recently developed as an automated system indicated 
to aspirate cells from the breast ducts. The objective of this study 
was to standardize the methodology of sampling and sample prepa-
ration of nipple discharge obtained by the automated method Halo 
breast test and perform cytological evaluation in samples preserved 
in liquid medium (SurePath™).
Methods: We analyzed 564 nipple fluid samples, from women be-
tween 20 and 85 years old, without history of breast disease and 
neoplasia, no pregnancy, and without gynecologic medical history, 
collected by HMCT method and preserved in two different vials 
with solutions for transport.
Results: From 306 nipple fluid samples from method 1, 199 (65%) 
were classified as unsatisfactory (class 0), 104 (34%) samples were 
classified as benign findings (class II), and three (1%) were clas-
sified as undetermined to neoplastic cells (class III). From 258 
samples analyzed in method 2, 127 (49%) were classified as class 
0, 124 (48%) were classified as class II, and seven (2%) were clas-
sified as class III.
Conclusion: Our study suggests an improvement in the quality and 
quantity of cellular samples when the association of the two meth-
odologies is performed, Halo breast test and the method in liquid 
medium.
Keyword: Breast cytology; Liquid based cytology; Atypical ductal 
cells; Ductal carcinoma
Introduction
The evaluation of methods to assist the clinical prediction of 
proliferative breast disease has been the objective of health 
professionals and specifically the ones focused on the early 
detection and prevention of breast cancer. Breast cancer is 
the second cause of death in women worldwide and, in Bra-
zil there were approximately 53,000 new cases in 2012 [1].
Screening of breast cancer can be done by clinical ex-
amination and mammography, and Brazilian Public Health 
Authorities indicate this protocol for women who are older 
than 40 years old; despite the quality inherent to the mam-
mogram test, the mortality rate is still high [2-4].
The spontaneous breast nipple discharge is characterized 
by the secretion of fluid through the breast nipples coming 
from mammary ducts. This material may contain cells that 
can be analyzed for malignancy. The study of this material is 
valuable for assessing possible cellular alterations associated 
to the malignant transformation in breast tissue, including 
precursor lesions [5-11].
Halo® Mamo Cyto Test (HMCT) was recently devel-
oped as an automated system indicated to aspirate cells from 
the breast ducts. The papillary fluid is obtained by a support 
adapted to the Halo system in order to promote the suction of 
the fluid material for cytological analyses. When preserved 
in appropriate liquid medium, as those used for uterine cer-
vix liquid-based cytology (LBC), it is possible to analyze 
Manuscript accepted for publication July 4, 2014
aInfectology Department, Faculty of Medicine, Federal University of 
 Sao Paulo; Santo Amaro University, Brazil
bIN CITO - Citologia Diagnostica Lab, Sao Paulo, Brazil
cMastology Section, Department of Gynecology, Faculty of Medicine, 
 Sao Paulo University, Brazil
dLaboratory of Medical Investigation (LIM) 14, Department of 
 Pathology, Faculty of Medicine, Sao Paulo University, Brazil
eLife and Health Sciences Research Institute (ICVS), School of Health 
 Sciences, University of Minho, Braga, Portugal; ICVS/3B’s - PT 
 Government Associate Laboratory, Braga/Guimaraes, Portugal; 
 Molecular Oncology Research Center, Barretos Cancer Hospital, 
 Barretos, Sao Paulo, Brazil
fMolecular Oncology Research Center, Barretos Cancer Hospital, Pio 
 XII Foundation, Barretos, Brazil
gCorresponding Author: Marco Antonio Zonta, Laboratorio 
 “IN CITO” - Citologia Diagnostica Ltda, Av: Tucuruvi 259, conj 
 14 - Tucuruvi, 02305-000, Sao Paulo, Brazil. 
 Email: marcozonta@terra.com.br
doi: http://dx.doi.org/10.14740/wjon844e
166                                                                                                                                                                                                                                                                                                                                                                                                                                             167
World J Oncol. 2014;5(4):166-174Zonta et al
Articles © The authors   |   Journal compilation © World J Oncol and Elmer Press Inc™   |   www.wjon.org
genomic and proteomic contents of the breast sample (data 
not published). This methodology emerges as a new alterna-
tive to obtain cells for the identification of possible atypical 
in early stages. It is easy to be used and typically tolerable 
for the patients [12].
The LBC that unquestionably offers better cytological 
preparations for gynecological samples is thought to be also 
better for breast material in terms of best cellular preserva-
tion. Also, as mentioned previously, the residual material can 
be used for molecular analyses proposals [13].
The objective of this study was to standardize a meth-
odology of sampling and sample preparation of nipple dis-
charge obtained by the automated method Halo breast test 




We analyzed 564 nipple fluid samples, from women between 
20 and 85 years old, without history of breast disease and 
neoplasia, no pregnancy, and without gynecologic history 
collected by HMCT method and preserved in two different 
vials solutions for transport. From the 564 samples, 306 were 
preserved in 8% solution of ethanol and 258 were preserved 
in SurePath™ vials for automatic processing. The project 
has been approved by the Ethics Commission for Analysis of 
Group I (159 women) Group II (130 women)
Age 20 - 85 20 - 85
Breast feeding
Yes 112 (70.44%) 112 (86.16%)
No 47 (29.56%) 18 (13.84%)
Family history of breast disease
Yes 99 (62.27%) 31 (23.84%)
No 60 (37.73%) 99 (76.16%)
Nipple discharge
Yes 67 (42.14%) 33 (25.39%)
No 92 (57.86%) 97 (74.61%)
History of breast disease
Yes 5 (3.15%) 31 (23.85%)
No 154 (96.85%) 99 (76.15%)
Table 1. Demographics and Social Status of Women Included in the Study
Figure 1. HAL breast test equipment.
Figure 2. Disable silicone cups, “Tulips”, used for col-
lecting fluid samples papillary.
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Research Projects (CAPPesq) and by the Ethics Committee 
of the Department of Obstetrics and Gynecology, Faculty of 
Medicine, University of Sao Paulo, on May 27, 2008 (Table 
1).
Automated nipple fluid papillary
Women were invited to participate in the project and the pro-
tocol was explained. After reading, agreeing and signing the 
term of informed consent, a questionnaire was conducted to 
obtain clinical and epidemiological data.
The procedures were performed in two stages, the first 
method was performed at the Gynecology Department of the 
Faculty of Medicine, University of Sao Paulo, Brazil and 
the material was preserved in medium based on ethanol and 
buffered. In the second stage, the material was collected at 
the Gynecology Department of Military Hospital of the Rio 
de Janeiro city, Brazil and preserved in SurePath™ medium.
In both arms, women were positioned to perform the 
collection procedure. A self-massage was applied for 10 min 
in each breast, starting the armpits and ending at the nipple. 
After the self-massage was completed, the cups that were 
supported around the nipple and aspiration cycle comprised 
of a light pressure and vacuum at an approximately 40 °C 
temperature were placed in order to obtain fluid material. 
The cups are composed of a disposable biocompatible poly-
mer (silicone). In sequence, we had the Halo cups opened 
and adjusted according to the size of the breasts on the areola 
region. The suction procedure of 5 min aspiration cycle was 
performed. After the procedure, we transferred the nipple 
fluid into vials and SurePath medium. The residual nipple 
fluid present in the areola region was collected using a swab 
and maintained into two respective recipients (Fig. 1-3).
Cytological preparation methodology (method 1)
From 306 nipples fluid sample obtained from right and left 
breasts and preserved in methanol. All the cellular material 
(1 mL) was subjected to vortex process for 15 s at 3,000 rpm. 
The cellular suspension was transferred to a conical tube and 
centrifuged for 10 min at 800 g to get a “pellet” of cells.
Tris buffer (Sigma) (1 mL) was added in the pellet that 
was homogenized and 1 mL was transferred to the slides 
with positive charge used to fix cells for 10 min. After the 
settling time (10 min) and cell attachment, material was de-
canted and washed with isopropyl alcohol and submitted to 
the automated staining.
Modified cytology method (method 2)
Two of the authors (MZ and FV) processed part of the sam-
ples using a new protocol methodology where 306 were 
Figure 3. Vial with liquid to preserve the cellular sam-
ples (SurePath™).
Method 1 Method 2 (modified by Zonta & Velame)
Preserved medium Methanol 8% SurePath ethanol-based medium
Technical procedure 1 mL of sample fluid 2 mL of sample fluid
Vortex 15 s/3,000 rpm Vortex 15 s/3,000 rpm
10 min at 800 g 10 min at 800 g
Cells pellet Cells pellet
1 mL of Tris buffer (Sigma) 1 mL of Tris buffer (Sigma)
1 mL of homogeneous cells pellet 1 mL of homogeneous cells pellet
10 m slyde fixing 20 m slyde fixing
Table 2. Methods Used for Obtaining Cellular Material for Cytological Analysis
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firstly preserved in 8% solution of methanol. Two hundred 
and fifty-eight (258) samples of the right and left breasts 
from 130 women were collected by automated HMCT. After 
preserving samples in a SurePath™ vial, the samples were 
subjected to a suspension process (vortex) for 15 s at 3,000 
rpm. Two milliliter of all samples was transferred to coni-
cal tube. The samples were centrifuged for 10 min at 800 g 
for cell pellet formation. The supernatant was removed and 
completed with 1 mL Tris buffer (Sigma) for homogeniza-
tion, 0.1 mL solution was transferred to delimit field area 
with slides charged positively for 20 min in order to have 
settlement and cell attachment; after that, the material was 
decanted and washed with isopropyl alcohol and again de-
canted to automate staining (Table 2).
Automated staining
The samples were stained in automated staining equipment 
(Prepmate™, BD, Burlington, USA). The cytological prepa-
rations were classified according to the National Statistics 
and The National Health Service Breast Screening Pro-
gramme [14] (Table 1).
Results
From 306 nipple fluid samples from method 1, 199 (65%) 
were classified as unsatisfactory (class 0); no cellular repre-
sentation was observed. These acellular samples exhibited 
a hyaline proteinaceous background. One hundred seven 
(35%) samples were classified as benign findings (class II). 
The smears were characterized by the presence of uniform 
groups of ductal cells, with round nuclei and single small 
nucleoli. The nuclear membrane showed regular borders and 
the cytoplasmic membrane showed well basophilic borders. 
Inflammatory mononuclear and multinucleated cells, ductal 
cells and foam cells were observed in proteinaceous back-
ground. Three (1%) samples showed cellular features with 
nuclear atypia, including nuclear hyperchromasia, discrete 
irregular chromatin, increased nucleus/cytoplasm ratio, and 
irregular borders of nuclear membrane and were classified 
as undetermined to neoplastic cells (class III) (Table 3, Fig. 
Table 3. Cytological Classification for Breast Screening Program
National Statistics and The National Health Service Breast Screening Programme (NHSBSP)
Class 0 Unsatisfactory material: absence of cells
Class II Negative for malignancy
Class III Indeterminate for malignancy
Class IV Suspicious for malignancy
Class V Positive for malignancy
Figure 4. (a) The presence of foam cells, inflammatory cells and cellular debris in basophilic pro-
teinaceous background. (b) The presence of ductal cells with increased nucleus/cytoplasm ratio 
and hyperchromatism nuclear and acidophilic cytoplasm. Presence of foam cells, mononuclear 
cells and cellular debris in basophilic proteinaceous background (method 1 - automated Papani-
colaou, × 40).
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4a, b).
From 258 samples analyzed in method 2, 127 (49%) had 
no cellularity and were classified as class 0, and 124 (48%) 
had cellularity with benign features and classified as class II. 
Ductal cells with cytomorphological characteristics within 
normal features were observed; there were also foam cells 
dispersed in hyaline proteinaceous background. Seven (2%) 
samples showed ductal cells with atypical nuclei showing 
hyperchromatic nuclei and irregular nuclear membrane and 
chromatin condensation were observed. The nucleoli were 
increased and hyperchromatic. The cytoplasms of the cells 
were frequently acidophilic and finely vacuolated. Cell clus-
ters with nuclear overlapping (class III) were observed. The 
smear background showed polymorphonuclear cells, blood 
cells in proteinaceous background (Table 4, Fig. 5a, b).
From 306 nipple fluid samples prepared by method 1, a 
higher frequency of benign lesions (61/19.93%) in women 
between 46 and 55 years old was observed. The major num-
ber of unsatisfactory (85/27.77%) samples was observed 
in the same age group. Three (0.96%) nipple fluid samples 
with atypical ductal cells, one (0.32%) from women between 
46 and 55 years old, one (0.32%) in sample from women 
between 56 and 65 year old and one (0.32%) sample from 
women between 66 and 75 years old (Table 5) were observed.
Concerning the nipple fluid sample prepared in method 
2, a higher frequency of benign finding (37/13.34%) in wom-
en between 46 and 55 years old and women between 36 and 
45 (32/12.40%) years old was observed (Table 6).
Also, a higher frequency of atypical cells (class III) 
(3/1.16%) was observed in women between 36 and 55 years, 
and two (0.77%) samples in women between 46 and 55 
years; one case (0.38%) in a woman between 26 and 35 years 
old and one (0.38%) between 76 and 85 years old. Unsatis-
factory samples were observed in 45 (17.44%) samples from 
women between 46 and 55 years old (Table 7).
Discussion
  
The standardization of methodologies which increases the 
Figure 5. (a) Ductal cells within the normal range in proteinaceous hyaline background. Absence of interfering cell 
and cellular debris was observed. (b) The presence of atypical ductal cells with hyperchromatic nuclei, dark chroma-
tin with granular deposit, irregular nuclear membrane, single prominent nucleoli, and a group of cellular overlapped. 
Cellular clusters, foam cells and mononuclear preserved in hyaline proteinaceous background were observed. Ab-
sence of interfering and debris cellular were observed (Zonta & Velame method - Papanicolaou automated, × 40).
Cellular changes Frequency (%)
Unsatisfactory 199 (65.0%)
Benign cells - class II 104 (34.0%)
Atypical cells - class III 3 (1.0%)
Total 306 (100%)
Table 4. Nipple Fluid Samples Collected in an Alcoholic Medium and Subjected to Manual Prepa-
ration and Stained by Automated Papanicolaou Method
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sensitivity and specificity in diagnosis is an important tool 
for the prevention and diagnosis of breast cancer. A good 
performance to obtain and preserve cellular material shall 
increase the possibility of finding cellular changes in initial 
stages, increasing the sensitivity of the findings in preven-
tions programs.
The use of methods which cause a little or no discomfort 
when obtaining samples for prevention and diagnoses and 
provide a better preservation of samples to be analyzed is 
of great value in early diagnosis of lesions with malignant 
potential.
The Halo breast test is a methodology that obtains cel-
lular material from the breast ducts aspirating from nipple 
while causing minimal discomfort to women. This method-
ology, when compared to mammography and fine-needle as-
piration cytology (FNAC) method proves to be significantly 
less painful, and it has been compared to the act of breast-
feeding. The score of pain reported by women is around 3.1. 
The score of pain reported by women who did the FNAC test 
and mammography was around 8.0 [15, 16].
The cytological test (Pap test) is a reference for iden-
tifying early lesions of the cervix, using the Papanicolaou 
method. The application of this methodology in other sites 
can provide important information, promoting the identifica-
tion of precursor lesions. The use of LBC showed an increase 
in quality of cellular samples, because preservation of the 
cells in a liquid solution could be improved. The preparation 
and stain samples can be automated. This procedure could be 
used as an alternative for identification of possible changes 
in cells in early stages, without signal of breast disease, an-
ticipating procedures such as fine-needle aspiration (FNA) 
and mammography.
Table 5. Cell Samples Prepared by the Automated Method (Zonta & Velame) and Stained by Automated 
Papanicolaou Method
Table 6. Frequency of Benign and Atypical Lesions in Women Evaluated by Method 1 (306 Sample, 100%)
Cellular changes Frequency (%)
Unsatisfactory - class 0 127 (49.0%)
Benign cells - class II 124 (48.0%)
Atypical cells - class III 7 (3.0%)
Total 258 (100%)
Women age (method 1)
Unsatisfactory (%) Benign cells (%) Atypical cells (%)
Class 0 Class II Class III
20 - 25 5 (1.63%) 3 (0.98%) 0 (0%)
26 - 35 10 (3.27%) 8 (2.61%) 0 (0%)
36 - 45 49 (16.01%) 12 (3.92%) 0 (0%)
46 - 55 85 (27.78%) 61 (19.93%) 1 (0.33%)
56 - 65 41 (13.40%) 13 (4.25%) 1 (0.33%)
66 - 75 8 (2.61%) 4 (1.31%) 1 (0.33%)
76 - 85 1 (0.33%) 3 (0.98%) 0 (0%)
Total of samples 199 (65.03%) 104 (33.98%) 3 (0.99%)
170                                                                                                                                                                                                                                                                                                                                                                                                                                             171
World J Oncol. 2014;5(4):166-174   Liquid-Based Medium Improves Cellular Samples
Articles © The authors   |   Journal compilation © World J Oncol and Elmer Press Inc™   |   www.wjon.org
Nipple breast fluid can offer a rich cellularity for analy-
ses. The ones present in ductal system normally are exfoli-
ated inside the duct and are eliminated as nipple fluid. The 
study of cellular material is very important because cellular 
change in this material can be identified and, cellular evi-
dence of malignity can also be identified. Lesions in initial 
stage can be obtained and identified in a little nipple secre-
tion, often preceding the clinical diagnosis and mammogra-
phy analysis [17, 18].
This aspect of the fluid may be an indicative of malignant 
Table 7. The Frequency of Benign and Atypical Lesions in Women Evaluated With Method 2
Women age (method 2)
Unsatisfactory (%) Benign cells (%) Atypical cells (%)
Class 0 Class II Class III
20 - 25 6 (2.32%) 4 (1.55%) 0 (0%)
26 - 35 15 (5.81%) 14 (5.43%) 1 (0.39%)
36 - 45 27 (10.46%) 32 (12.40%) 3 (1.16%)
46 - 55 45 (17.44%) 37 (13.34%) 2 (0.77%)
56 - 65 13 (5.04%) 25 (9.69%) 0 (0%)
66 - 75 12 (4.65%) 6 (2.32%) 0 (0%)
76 - 85 9 (3.49%) 6 (2.32%) 1 (0.39%)
Total of samples 127 (49.17%) 124 (48.05%) 7 (2.71%)
Total  258 (100%)  
Figure 6. Guideline of clinical practice after aspiration cytology of the mammary papilla.
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disease of the breast. The presence of crystalline or bloody 
material in either unilateral or bilateral nipple discharge, 
with single ductal conduit affected and persistent secretion 
are indicators of malignant breast disease. Although a small 
percentage (2-2.5%), women who have these characteristics 
are diagnosed with a malignant disease of the breast [19, 20].
Material from nipple discharge showed around 35% of 
sensitivity to identify precancerous lesion a malignant cells 
for breast cancer, and 70% of this material is classified as 
suspicious, because they showed important nuclear changes 
with atypical forms and size. This could lead to screening 
FNA providing preliminary results, increasing the accuracy 
in the diagnosis of breast diseases [21, 22].
The standardization of methodology for studying this 
material provides a breakthrough not only in the early iden-
tification of breast lesions, but also the creation of control 
programs, that can be applied in populations at risk of devel-
oping the disease.
The best preservation of cellular material obtained by 
FNAC or nipple aspirate increased the diagnostic sensitivity. 
Mygdakos et al, comparing cell samples of breast, thyroid 
and salivary glands, found improvements of cytomorpho-
logical characterization of the samples prepared in liquid 
medium compared to the conventional method. It is also im-
portant to highlight the necessity of having better training for 
the professionals who are involved in cytological diagnosis 
[23].
Our study showed two distinct profiles, the one who 
had collected material prepared by the conventional method, 
showed the presence of degenerated ductal cells, with loss 
of nuclear and cytoplasmic characteristics. A background 
smear showed a hyaline amorphous material filled with cel-
lular elements degenerated.
There was a high rate of unsatisfactory samples, sug-
gesting that the lack of standardization when preparing 
smears can be decisive in the loss of quality of the cells. In 
cases classified as atypical, it was difficult to observe some 
important nuclear characteristics, such as hyperpigmentation 
marked irregularity of the nuclear membrane due to virtue of 
the degree of degeneration of the smears [24].
Samples can be well observed in smears collected by 
FNAC, which have a large amount of red blood cells and cel-
lular debris due to the technique of harvesting the material. 
The insufficient fixation and overlapping artifacts on cells 
with possible morphological changes may hinder the cyto-
logical diagnosis [13].
The association between Halo breast test and cellular 
material was preserved in liquid (SurePath), and it was ob-
served that cell morphology is maintained. The ductal cells 
had evident nuclear features well distributed in chromatin, 
and prominent nucleoli preserved and regular nuclear mem-
brane. The cytoplasm was well preserved. In the cases classi-
fied as atypical, the presence of cell overlapping with nucle-
ar atypia and hyperchromatic nuclei with irregular nuclear 
membrane was clear. The background of the smears showed 
up clean, reducing the cell pellet and blood cells, allowing a 
better position to evaluate the cellular findings.
When the methods of the samples preparation were 
modified, and the method we are introducing was applied, a 
decreased number of unsatisfactory samples (65% to 49%) 
were observed. It is a very important finding, since the num-
ber of unsatisfactory samples is reduced and the chances of 
finding cells modification and identifying lesions in initial 
stages shall be increased. We presume that the appropriate 
cell concentration and a better representation of the material 
in cytological preparation, without background interference, 
may increase the sensitivity of cytological examination (data 
not shown). This method increases the chances of identify-
ing atypical cells, since the morphological changes could be 
better identified and characterized.
The presence of atypical cells (class III) in women be-
tween 35 and 55 years old was identified in both methods. 
The identification of atypical cells in women before 40 years 
old is an important predictor of the presence of premalignant 
lesion. These results suggest that this method could be an im-
portant option to improve the early identification of lesions 
and guiding the clinician to a possible need to anticipate the 
search clinic investigation. It is an important finding since 
the test which is used to prevent breast lesion (mammogra-
phy) is indicated to women over 40 years old. HMCT shall 
collect samples in women over 30 years old, increasing the 
chances to identify lesions in initial stages (Fig. 6).
The alternative methodology we have reported detected 
3.0% of atypical cells in contrast to the traditional prepara-
tion that showed 1.0%. When the conventional method was 
modified, the additional centrifugation procedure showed 
more effectiveness in cell concentration in the sample.
Based on the study of Filassi, 2012, at all, the author 
suggests a protocol to follow these women as shown below.
Conclusion
Our study demonstrated an improvement in the quality and 
quantity of cellular analyses when we associated two meth-
odologies to prepare nipple cytological samples collected, 
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